CONMED (CNMD) director Ann Golden, Sold $372,649 in Stock; Capwealth Advisors Has Increased By $703,912 Its Cisco Systems (CSCO) Holding

Cisco Systems, Inc. (NASDAQ:CSCO) Logo

Capwealth Advisors Llc increased Cisco Systems Inc (CSCO) stake by 4.98% reported in 2017Q4 SEC filing. Capwealth Advisors Llc acquired 18,524 shares as Cisco Systems Inc (CSCO)’s stock rose 10.71%. The Capwealth Advisors Llc holds 390,412 shares with $14.95M value, up from 371,888 last quarter. Cisco Systems Inc now has $213.37B valuation. The stock decreased 0.94% or $0.42 during the last trading session, reaching $44.29. About 14.92 million shares traded. Cisco Systems, Inc. (NASDAQ:CSCO) has risen 25.57% since May 1, 2017 and is uptrending. It has outperformed by 14.02% the S&P500.

Among 38 analysts covering Cisco Systems Inc. (NASDAQ:CSCO), 26 have Buy rating, 0 Sell and 12 Hold. Therefore 68% are positive. Cisco Systems Inc. had 156 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of Cisco Systems, Inc. (NASDAQ:CSCO) has “Outperform” rating given on Friday, November 13 by RBC Capital Markets. The stock of Cisco Systems, Inc. (NASDAQ:CSCO) has “Buy” rating given on Thursday, January 18 by KeyBanc Capital Markets. Robert W. Baird maintained the shares of CSCO in report on Friday, October 13 with “Buy” rating. BMO Capital Markets downgraded the stock to “Market Perform” rating in Tuesday, May 9 report. Piper Jaffray maintained Cisco Systems, Inc. (NASDAQ:CSCO) on Wednesday, August 16 with “Buy” rating. The stock of Cisco Systems, Inc. (NASDAQ:CSCO) has “Buy” rating given on Wednesday, August 17 by Jefferies. The stock has “Overweight” rating by Barclays Capital on Thursday, August 18. The company was downgraded on Tuesday, August 4 by Zacks. Robert W. Baird maintained the stock with “Buy” rating in Thursday, February 15 report. KeyBanc Capital Markets maintained it with “Overweight” rating and $33 target in Thursday, August 18 report.

Investors sentiment increased to 1.03 in 2017 Q4. Its up 0.01, from 1.02 in 2017Q3. It improved, as 51 investors sold CSCO shares while 660 reduced holdings. 145 funds opened positions while 589 raised stakes. 3.54 billion shares or 1.52% less from 3.60 billion shares in 2017Q3 were reported. Gargoyle Investment Advisor Ltd holds 45,304 shares. Harbour Inv Limited Liability Corporation reported 58,045 shares or 1.57% of all its holdings. Metropolitan Life Insurance Company Ny accumulated 759,919 shares. Flossbach Von Storch Ag reported 16,340 shares. Botty Invsts Ltd Liability Corporation invested in 42,600 shares or 0.51% of the stock. Mark Sheptoff Planning Limited Liability Corporation invested in 0.27% or 10,900 shares. Pinnacle Ltd Company holds 0.25% of its portfolio in Cisco Systems, Inc. (NASDAQ:CSCO) for 17,880 shares. Fincl Bank has invested 1.6% in Cisco Systems, Inc. (NASDAQ:CSCO). Spectrum Management Group Inc Incorporated owns 1.03% invested in Cisco Systems, Inc. (NASDAQ:CSCO) for 77,500 shares. Pettee Investors reported 0.27% stake. Miller Invest Management LP invested 0.26% in Cisco Systems, Inc. (NASDAQ:CSCO). Kornitzer Management Ks holds 0.67% or 1.02M shares in its portfolio. Lathrop Inv Mgmt reported 4.15% of its portfolio in Cisco Systems, Inc. (NASDAQ:CSCO). Cranbrook Wealth Mngmt accumulated 100 shares. Alphamark Advsrs Ltd Liability Corporation holds 0.01% in Cisco Systems, Inc. (NASDAQ:CSCO) or 917 shares.

Since December 14, 2017, it had 0 insider buys, and 5 selling transactions for $10.28 million activity. BARTZ CAROL had sold 200,000 shares worth $7.59 million. MCGEARY RODERICK C sold 15,230 shares worth $578,740. SARIN ARUN sold $625,751 worth of stock or 14,189 shares. Another trade for 12,126 shares valued at $550,153 was made by BURNS M MICHELE on Monday, February 26. Shares for $940,559 were sold by Goeckeler David.

CONMED Corporation, a medical technology company, develops, makes, and sells surgical devices and related equipment for minimally invasive procedures in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company has market cap of $1.82 billion. The firm offers sports medicine products, such as powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, metal and bio absorbable implants, and related disposable products and fluid management systems; powered surgical instruments for use in large and small bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; and sports biologics and tissues. It has a 33.01 P/E ratio. It also provides electrosurgical generators, hand pieces, smoke management systems, and accessories for surgical needs; and endomechanical instrumentation products that offer various instruments comprising trocars, suction irrigation devices, graspers, scissors, and dissectors used in the minimally invasive laparoscopic and gynecological surgery, as well as an uterine manipulator for use in the laparoscopic hysterectomies and other gynecologic laparoscopic procedures.

Ann Golden, an insider of Conmed Corp, currently director lately disclosed a trade with the D.C. based-SEC. As reported in the legal form, Ann Golden made a sale of 5,698 shares of the Pinksheet-listed Conmed Corp, priced at $65.4 per share. $372,649 U.S Dollars was the trade’s value. The SEC report’s date was 30/04/2018. Ann Golden currently owns 13,782 shares or 0.05% of Conmed Corp’s total market cap.

Among 6 analysts covering CONMED Corporation (NASDAQ:CNMD), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. CONMED Corporation has $7300 highest and $44 lowest target. $55.50’s average target is -14.65% below currents $65.03 stock price. CONMED Corporation had 19 analyst reports since July 22, 2015 according to SRatingsIntel. Needham maintained CONMED Corporation (NASDAQ:CNMD) rating on Thursday, February 1. Needham has “Buy” rating and $71.0 target. The stock has “Buy” rating by Needham on Thursday, July 27. The stock of CONMED Corporation (NASDAQ:CNMD) has “Buy” rating given on Thursday, August 31 by Needham. The stock of CONMED Corporation (NASDAQ:CNMD) earned “Hold” rating by Piper Jaffray on Friday, November 3. The company was maintained on Wednesday, August 23 by KeyBanc Capital Markets. The company was maintained on Thursday, April 28 by Needham. The firm has “Buy” rating given on Friday, November 17 by Needham. Northland Capital maintained it with “Market Perform” rating and $44 target in Thursday, October 22 report. The firm has “Hold” rating by KeyBanc Capital Markets given on Friday, November 3. The rating was upgraded by Ladenburg Thalmann to “Buy” on Monday, October 12.

Investors sentiment decreased to 1.3 in 2017 Q4. Its down 0.04, from 1.34 in 2017Q3. It is negative, as 7 investors sold CONMED Corporation shares while 46 reduced holdings. 25 funds opened positions while 44 raised stakes. 26.91 million shares or 0.87% less from 27.14 million shares in 2017Q3 were reported. Blackrock Inc has invested 0.01% in CONMED Corporation (NASDAQ:CNMD). Fifth Third Bank & Trust accumulated 128 shares. Counselors Of Maryland Ltd Liability Corporation has 300,613 shares. Royal Fincl Bank Of Canada has 0% invested in CONMED Corporation (NASDAQ:CNMD) for 15,886 shares. Retail Bank Of Montreal Can has invested 0% in CONMED Corporation (NASDAQ:CNMD). Grp Inc One Trading Lp stated it has 0% of its portfolio in CONMED Corporation (NASDAQ:CNMD). Zebra Capital Ltd Liability invested in 0.31% or 18,216 shares. Price T Rowe Associates Md holds 0% of its portfolio in CONMED Corporation (NASDAQ:CNMD) for 11,620 shares. Services Automobile Association holds 0% or 31,097 shares. Oppenheimer Asset Mgmt accumulated 4,486 shares. Bank Of America De owns 68,985 shares. Deutsche National Bank Ag owns 72,534 shares. Axa reported 36,540 shares. Gsa Capital Prtn Llp owns 15,264 shares or 0.05% of their US portfolio. Assetmark owns 8 shares.

Since January 3, 2018, it had 1 insider purchase, and 5 sales for $2.91 million activity. Shares for $7,996 were bought by Farkas Charles on Wednesday, January 3. 3,000 shares were sold by GOLDEN JO ANN, worth $191,694. POMILIO LUKE A had sold 18,023 shares worth $1.14M on Thursday, February 1. 3,868 CONMED Corporation (NASDAQ:CNMD) shares with value of $241,574 were sold by Berge Terence M.

The stock decreased 0.34% or $0.22 during the last trading session, reaching $65.03. About 231,618 shares traded or 18.69% up from the average. CONMED Corporation (NASDAQ:CNMD) has risen 46.44% since May 1, 2017 and is uptrending. It has outperformed by 34.89% the S&P500.

CONMED Corporation (NASDAQ:CNMD) Institutional Positions Chart